Stock DNA
Chemicals & Petrochemicals
CNY 2,630 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-8.99
328.57%
-26.51
Revenue and Profits:
Net Sales:
119 Million
(Quarterly Results - Jun 2025)
Net Profit:
-117 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.91%
0%
2.91%
6 Months
-20.29%
0%
-20.29%
1 Year
89.76%
0%
89.76%
2 Years
8.96%
0%
8.96%
3 Years
-54.24%
0%
-54.24%
4 Years
-56.14%
0%
-56.14%
5 Years
-51.62%
0%
-51.62%
Ningxia Zhongke Biotechnology Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
15.46%
EBIT Growth (5y)
-230.09%
EBIT to Interest (avg)
-2.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
32.15
Sales to Capital Employed (avg)
0.42
Tax Ratio
0.99%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-26.51
EV to EBIT
-9.47
EV to EBITDA
-14.43
EV to Capital Employed
4.44
EV to Sales
8.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.94%
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
119.20
91.80
29.85%
Operating Profit (PBDIT) excl Other Income
-48.00
-30.50
-57.38%
Interest
9.70
3.40
185.29%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-116.80
-72.80
-60.44%
Operating Profit Margin (Excl OI)
-669.60%
-678.50%
0.89%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 29.85% vs -41.97% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -60.44% vs 6.79% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
336.30
279.30
20.41%
Operating Profit (PBDIT) excl Other Income
-81.40
-64.60
-26.01%
Interest
145.40
142.60
1.96%
Exceptional Items
-44.00
-210.00
79.05%
Consolidate Net Profit
-577.00
-515.30
-11.97%
Operating Profit Margin (Excl OI)
-617.00%
-728.40%
11.14%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 20.41% vs -58.62% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -11.97% vs -202.94% in Dec 2023
About Ningxia Zhongke Biotechnology Co., Ltd. 
Ningxia Zhongke Biotechnology Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






